Phase 3, open label, single arm study to evaluate efficacy and safety of FIX gene transfer with PF-06838435 (rAAV-Spark100-hFIX-Padua) in adult male participants with moderately severe to severe hemophilia B (FIX:C =2%) (BeneGene-2) (NCT03861273)
C0371002
This trial is No longer recruiting
Registration number NCT03861273
Program & service
This trial is being run with the Cancer service, and as part of the Haemophilia program.
Trial phase
Phase 3
Trial participation type
This trial has been designed for the Clinical Research of a Drug.
Principal investigator
Professor Huyen Tran
More information
To find out more about this clinical trial, please review full details on the ANZCTR website.
View on ANZCTR